The prognostic predictive SER model for NK/T-cell lymphoma in the era of modern immunotherapy

Based on routine blood tests and clinical data, the SER model for ICI therapy of NKTCL-optimized with the RF algorithm and incorporating Ann Arbor stage and ECOG-demonstrates superior predictive performance compared to PINK-E and NRI. It provides a valuable reference for early prediction of ICI therapy failure and long-term survival.